Influenza vaccination rates are declining while flu cases continue to rise, creating significant challenges for health system capacity and operations. In this episode, Amanda Cohn, MD, Medical Head of Influenza and COVID, North America, Vaccines, Sanofi, explains the clinical and operational impact of low vaccination coverage on health systems and discuss evidence-based strategies that leaders can implement to improve immunization rates and strengthen system resilience during respiratory season.
Selected Podcast
From Reactive to Resilient: Rethinking Health System Strategy for Flu Season
Amanda Cohn, MD
Dr. Amanda Cohn is the Medical Head of Influenza and COVID Vaccines for Sanofi, North America. She is responsible for leading medical strategy and initiatives for Sanofi's influenza and COVID vaccine programs across the region.
With over twenty years of distinguished public health experience, Dr. Cohn comes to Sanofi from the Centers for Disease Control and Prevention (CDC), where she held several senior leadership roles. As Executive Secretary of the Advisory Committee on Immunization Practices (ACIP), she spearheaded the introduction of the Evidence to Recommendations framework for U.S. vaccine policy development. She also served as Chief Medical Officer of the National Center for Immunization and Respiratory Diseases and as deputy director of the Immunization Services Division, which manages the Vaccines for Children program. From 2020–2024, she was a member of the FDA's Vaccines and Related Biologics Policy Advisory Committee. She retired as a Captain in the US Public Health Service.
A graduate of Emory University in Atlanta, GA, Dr. Cohn earned her Doctor of Medicine degree before completing her pediatric residency at the Boston Combined Residency in Pediatrics.
From Reactive to Resilient: Rethinking Health System Strategy for Flu Season
Melanie Cole, MS (Host): Welcome to the Healthcare Executive podcast, providing you with insightful commentary and developments in the world of healthcare leadership.
Sanofi is one of ACHE's premier corporate partners. Our premier corporate partners support ACHE's vision and mission to advance healthcare leadership excellence. For more information on Sanofi, please visit the corporate partners page at ache.org.
I'm your host today, Melanie Cole. And influenza vaccination rates are declining while flu cases continue to rise, creating significant challenges for health system capacity and operations. In this episode, we're exploring the clinical and operational impact of low vaccination coverage on health systems and evidence-based strategies that leaders can implement to improve immunization rates and strengthen system resilience during respiratory season. From reactive to resilient: rethinking health system strategy for flu season.
Today, we're joined by Dr. Amanda Cohn. She's the medical head of Influenza and COVID North America Vaccines, Sanofi. She's responsible for leading medical strategy and initiatives for Sanofi's influenza and COVID vaccine programs across the region. Dr. Cohn, thank you so much for joining us today. As we get into this topic, briefly tell us about your background a little bit and your perspective on vaccination and public health.
Dr. Amanda Cohn: Sure. Thank you, Melanie, and thank you so much for having me join you today. So, I'm a licensed pediatrician. And before I joined Sanofi, I worked for over 20 years at the US Centers for Disease Control, where I focused on vaccine-preventable disease, epidemiology, immunization policy, and implementation.
Towards the end of my career, I served as the CDC lead for the Advisory Committee on Immunization Practices, where I helped develop the child and adult immunization schedule, and I worked on far too many vaccine-preventable disease outbreaks, including measles outbreaks and the COVID pandemic and earlier influenza outbreaks.
I was drawn to vaccine-preventable diseases after spending a summer working at a hospital in the Philippines while I was in medical school. I saw firsthand the devastating effect of diseases we rarely see in the US, such as measles, neonatal tetanus, rabies, and Hib meningitis. These are things that pediatricians almost never see anymore.
So throughout my career, I've seen firsthand how vaccines are one of the most effective tools we have to prevent illness, reduce complications, and save lives in the US and globally. As a pediatrician, I am especially proud that in children we've seen hospitalizations from rotavirus diarrhea and now RSV plummet after vaccine introduction.
Early in my career, I got to inform vaccine policy to protect against meningococcal disease, which has a 10% mortality rate and a 20% rate of severe outcomes, such as amputation or hearing loss. When I first started, we had about three hundred cases of meningococcal disease among adolescents each year. And since we've implemented routine vaccination, we have less than 40 cases a year in that same age group.
So from both clinical practice and population health perspectives, immunization is just foundational to keeping individuals healthy and ensuring healthcare systems function effectively. So, I feel very privileged to have been part of that story and worked at CDC for 20 years, and I'm very excited to be at Sanofi now.
Melanie Cole, MS: Well, thank you so much for sharing all of that, and thank you so much for all that great work that you have been doing on behalf of public health and especially for our children, our little kiddos, because that's really what this is about. And Dr. Cohn, as we think about it now, what's the current challenge that you see facing health systems when it comes to flu vaccination?
Dr. Amanda Cohn: So as you know, influenza affects both children, young children especially, as well as older adults and persons with underlying health conditions. Influenza is often underestimated and continues to drive substantial disease burden each year. And we never know if we're going to have a serious influenza season or a less serious influenza season. During the 2024 to '25 season alone, there were an estimated 51 million influenza illnesses, 710,000 hospitalizations and 45,000 deaths were attributed to influenza in the US.
.However, at the same time, we're seeing declining vaccination rates and growing patient hesitancy, which really creates significant vulnerability across communities and health systems. Patients are increasingly taking a more active role in evaluating and making healthcare decisions, which is great. But this does require health systems across the spectrum to work harder to earn patient trust and demonstrate the value and importance of influenza vaccination.
Melanie Cole, MS: Well then, what happens to health systems and hospitals when flu vaccination coverage declines?
Dr. Amanda Cohn: So with each percentage of flu vaccination decline, we will see more hospitalizations and more deaths each year. And where in the United States that happens each year in terms of density or severity of influenza is really quite an unknown, which is why it's really important to have high immunization coverage across communities. So when fewer patients are immunized, we have larger and more unpredictable seasonal surges. And particularly when flu overlaps with other seasonal surges from other respiratory illnesses like COVID, and RSV, and parainfluenza virus, this can really put strain on healthcare system capacity. You can have staffing shortages and disruptions to routine care delivery. We all saw that during COVID, and we've seen that during prior influenza major serious seasons. But I think that was most seen during early in the COVID pandemic.
In hospitals and health systems, the impact is both clinical and operational. So, you have higher patient volumes, which are driven by flu-related complications. So, it's not just influenza disease itself, it's the complications, especially in individuals with underlying healthcare conditions. It's the cardiac complications and the pneumonia complications that put them at higher risk for both disease and hospitalization. We also can have overcrowded emergency departments and longer wait times. We see that to some extent many winters, but it can be greater or smaller depending on the severity of the season. And we have increased ICU utilization, especially among older adults and patients with chronic conditions. And finally, flu among staff and their families can cause increased absenteeism and staffing shortages.
Modeling studies show that low influenza vaccination rates significantly increase outpatient visits, hospitalizations, ICU use, and strain on healthcare infrastructure. And so, specifically in high incidence seasons, vaccination rates below 45% may lead to saturation of ICU capacity.
Melanie Cole, MS: Well, I know that triple threat, RSV, COVID, and influenza really threw systems for a loop for a while now. And as we think about ways to mitigate and strategize, why should health system executives view flu vaccination in itself as a strategic priority?
Dr. Amanda Cohn: So, I think it's really critical both for healthcare systems and to protect patients that health systems shift from crisis management, reacting to these triple threats and to these really major viral disease seasons to proactive care, which means really getting people vaccinated in their healthcare systems as much as possible early.
And this can be a real strategic lever, not just to improve clinical outcomes, but for system performance. This can help stabilize seasonal hospitalizations and reduce unpredictable spikes. It can protect workforce capacity, and it can really support achievement in quality and population health goals, including things like rehospitalization and long-term outcomes from influenza disease.
So, we know that immunization programs align directly with broader priorities like value-based care and health equity and preventive health outcomes, which are really key to protecting communities and the patients that healthcare systems take care of. And so, leaders who prioritize vaccination are better positioned to maintain operational resilience during respiratory season, but also do what's best for their patients.
Melanie Cole, MS: Certainly, this is such an important topic we're discussing here today, Dr. Cohn. So, how can health systems take action? Take us from bench to bedside here to improve the flu vaccination rates as they stand right now.
Dr. Amanda Cohn: I say all of this knowing that improving influenza vaccination rates is not easy. It is critically important. And in this moment, it's become even more challenging than I would say prior to the pandemic. And this is what we're seeing with declining rates. But there are things that can be done, and I think it's both systems approach. It happens at every level, right? It happens in communities, it happens in health systems, and it happens at that provider one-on-one patient interaction.
So, success requires a coordinated systems-wide approach. We need to do better at embedding vaccination into standard clinical workflows, including inpatient settings, outpatient settings, emergency care settings. We should be finding every opportunity to offer vaccination to patients, influenza vaccination to patients during influenza season. We can also use our healthcare information technology to identify unvaccinated patients, especially those with chronic health conditions, and older adults, and young children, and enable reminders and alerts and help with ease of scheduling.
Knowing that there are barriers for patients to getting vaccinated, it can be hard for them to get there and to find time in their day to get that vaccine. And we can also empower clinicians with clear, consistent messaging to recommend vaccination confidently.
There was a survey done by the National Foundation for Infectious Diseases in 2025, which reinforced how many misconceptions there are about flu and influenza vaccine. And so, as the most trusted source of information, healthcare professionals are best positioned to share this knowledge and provide guidance. And I know those conversations are taking longer, and people are coming to the office with more questions. And those questions are important that they be answered. And a provider may not get that individual vaccinated at that visit, but hopefully the next visit that person will get vaccinated.
Healthcare systems can also expand access to immunization through community partners and non-traditional settings. Make sure that there are opportunities for people to get vaccinated outside of appointments. And this can also help build trust, right? So, many patients can't make an appointment. Hosting flu vaccine clinic events in the community over the weekend, connected to other health fair events can both increase access to flu vaccine and demonstrate your organization's belief in the importance of preventive care and flu vaccination. And so, I think that's another really nice way to demonstrate how important it is to protect communities.
Overall, it's really important to meet patients where they are. I can't reiterate enough how I think many times in this current environment, people are coming in with misconceptions and don't understand why flu vaccine is important to them.
And so, one of the things I like to say is when you know your patient, right? Flu vaccine's important because you're going to be around your grandchildren, and you want to make sure that you're healthy, and you want to protect your grandchildren as well, or it's an important part of your heart disease management. So, there's lots of ways to individualize those recommendations to your patient.
Melanie Cole, MS: Well, I thank you for using words like confidence for the providers when they're getting these questions, which are so prevalent today, especially with the internet. You know, people look this stuff up and they see all kinds of things. And you used the word trust, Dr. Cohn, because I think that is one of the crux of what you're discussing here today, is trust in the medical community, which is vital to increase these rates of vaccination. So, where is the role of leadership? You've spoken about the role of the provider with their patients directly. Where does leadership come into play in driving this progress?
Dr. Amanda Cohn: Yeah. I think reiterating that word trust, it is super important. And it can't just happen in that provider-to-patient interaction. Trust is built over the span of the whole healthcare encounter. So, beyond the healthcare provider/practitioner-to-patient interaction, leadership can really play a role in making sure that the whole staff, the whole community of people engaging with patients understand the value of influenza vaccination.
So from the moment a patient is checked in to the moment a patient is seen in the ER, there's so many opportunities, and all of those staff members need to understand and believe in the importance of influenza vaccination, both for those patients and for the healthcare system.
So, leadership is really how we can turn that knowledge into action. We have effective vaccines. They're not perfect. Influenza vaccines may not always prevent somebody from getting influenza, but we know that they are very, very good at preventing severe disease and hospitalization and death. And we have years and years of data on the safety of these vaccines. And so, we need to turn that into an impact on patients' health and reducing the healthcare system burden.
This requires an investment by leaders into building vaccination into the culture of an organization. So, rather than putting the responsibility onto the individual clinician, healthcare system leaders need to make this a visible priority. So, this requires setting clear goals and accountability, providing adequate resources and appropriate tools to all parts of that healthcare team, and then linking vaccination to quality and performance metrics.
And I think, even just offering vaccination over and over again, patients need to hear things from multiple different angles and from multiple people. And so, all of those things can be driven by leadership. So ultimately, progress comes from creating a system in which the evidence, the recommendation, and the whole patient experience point to the same direction. And leadership can help align all of those pieces and translate them into action.
Melanie Cole, MS: That's such an important point. This is so fascinating what you're discussing today, so interesting and really so important. As we wrap up, if you could leave healthcare system leaders with one key takeaway, what would you want to tell them, Dr. Cohn, about the importance of these discussions, these strategies, these promotions, being involved in the communities to get more people vaccinated?
Dr. Amanda Cohn: It's hard to come up with just one key takeaway. But I would say that one injection in one moment can provide a season of protection. And so, preventing flu is far easier and far more effective than managing its consequences.
And so, as healthcare is getting more complex and complicated, flu vaccination remains a really important tool to reduce the stress on communities and healthcare systems in influenza season. But this opportunity is really bigger than flu season. It's about building a healthcare model that anticipates risk rather than responding to it. So, using things like interventions like influenza vaccination can help make health systems more resilient year after year.
And I know, you know, we always talked at CDC about the importance of having high influenza immunization coverage rates to prepare us for a pandemic, right? But it's about each season, it's about the next season, and it's about making sure that we have trust and confidence for when we do have that next very serious influenza season.
Melanie Cole, MS: What great information you've given here today, Dr. Cohn. I thank you so much for joining us and sharing your incredible expertise and experience with us today. So, thank you so much again.
And Sanofi is one of ACHE's premier corporate partners. Our premier corporate partners support ACHE's vision and mission to advance healthcare leadership excellence. For more information on Sanofi, please visit the corporate partners page at ache.org. And for more information, please visit healthcareexecutive.org.
If you enjoyed this podcast, please share it on your social channels and check out the entire Healthcare Executive Podcast library for topics of interest to you. I'm your host, Melanie Cole, and this is the Healthcare Executive Podcast. Thank you so much for joining us today.